K. Nouri-aria, R. Sallie, M. Mizokami, B. Portmann, and R. Williams, Intrahepatic expression of hepatitis C virus antigens in chronic liver disease, The Journal of Pathology, vol.44, issue.1, pp.77-83, 1995.
DOI : 10.1002/path.1711750112

L. Seeff, Natural history of chronic hepatitis C, Hepatology, vol.349, issue.S1, pp.35-46, 2002.
DOI : 10.1002/hep.1840360706

M. Al-sherbiny, A. Osman, N. Mohamed, M. Shata, F. Abdel-aziz et al., Exposure to hepatitis C virus induces cellular immune responses without detectable viremia or seroconversion, Am J Trop Med Hyg, vol.73, pp.44-49, 2005.

J. Post, Y. Pan, A. Freeman, C. Harvey, P. White et al., Clearance of Hepatitis C Viremia Associated with Cellular Immunity in the Absence of Seroconversion in the Hepatitis C Incidence and Transmission in Prisons Study Cohort, The Journal of Infectious Diseases, vol.189, issue.10, pp.1846-1855, 2004.
DOI : 10.1086/383279

J. Orland, T. Wright, and S. Cooper, Acute hepatitis C, Hepatology, vol.33, issue.2, pp.321-327, 2001.
DOI : 10.1053/jhep.2001.22112

D. Bowen and C. Walker, Adaptive immune responses in acute and chronic hepatitis C virus infection, Nature, vol.38, issue.7053, pp.946-952, 2005.
DOI : 10.1128/JVI.78.3.1575-1581.2004

G. Lauer and B. Walker, Hepatitis C Virus Infection, New England Journal of Medicine, vol.345, issue.1, pp.41-52, 2001.
DOI : 10.1056/NEJM200107053450107

J. Feld and J. Hoofnagle, Mechanism of action of interferon and ribavirin in treatment of hepatitis C, Nature, vol.128, issue.7053, pp.967-972, 2005.
DOI : 10.1126/science.1114016

A. Neumann, N. Lam, H. Dahari, D. Gretch, T. Wiley et al., Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon- Therapy, Science, vol.282, issue.5386, pp.103-107, 1998.
DOI : 10.1126/science.282.5386.103

A. Freeman, Y. Pan, C. Harvey, J. Post, M. Law et al., The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection, Journal of Hepatology, vol.38, issue.3, pp.349-356, 2003.
DOI : 10.1016/S0168-8278(02)00424-5

D. Schuppan, A. Krebs, M. Bauer, and E. Hahn, Hepatitis C and liver fibrosis, Cell Death and Differentiation, vol.10, issue.S1, pp.59-67, 2003.
DOI : 10.1038/sj.cdd.4401163

M. Fried, M. Shiffman, K. Reddy, C. Smith, G. Marinos et al., Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection, New England Journal of Medicine, vol.347, issue.13, pp.975-982, 2002.
DOI : 10.1056/NEJMoa020047

S. Zeuzem, M. Diago, E. Gane, K. Reddy, P. Pockros et al., Peginterferon alfa-2a (40 kilodaltons) and ribavirin in patients with chronic hepatitis C and normal aminotransferase levels, Gastroenterology, vol.127, issue.6, pp.1724-1732, 2004.
DOI : 10.1053/j.gastro.2004.09.050

M. Manns, J. Mchutchison, S. Gordon, V. Rustgi, M. Shiffman et al., Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial, The Lancet, vol.358, issue.9286, pp.958-965, 2001.
DOI : 10.1016/S0140-6736(01)06102-5

D. Strader, T. Wright, D. Thomas, and L. Seeff, Diagnosis, management, and treatment of hepatitis C, Hepatology, vol.24, issue.suppl, pp.1147-1171, 2004.
DOI : 10.1002/hep.20119

S. Zeuzem, J. Pawlotsky, E. Lukasiewicz, M. Von-wagner, I. Goulis et al., International, multicenter, randomized, controlled study comparing dynamically individualized versus standard treatment in patients with chronic hepatitis C, Journal of Hepatology, vol.43, issue.2, pp.250-257, 2005.
DOI : 10.1016/j.jhep.2005.05.016

P. Farci, H. Alter, S. Govindarajan, D. Wong, R. Engle et al., Lack of protective immunity against reinfection with hepatitis C virus, Science, vol.258, issue.5079, pp.135-140, 1992.
DOI : 10.1126/science.1279801

T. Von-hahn, J. Yoon, H. Alter, C. Rice, B. Rehermann et al., Hepatitis C Virus Continuously Escapes From Neutralizing Antibody and T-Cell Responses During Chronic Infection In Vivo, Gastroenterology, vol.132, issue.2, pp.667-678, 2007.
DOI : 10.1053/j.gastro.2006.12.008

S. Khakoo, C. Thio, M. Martin, C. Brooks, X. Gao et al., HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection, Science, vol.305, issue.5685, pp.872-874, 2004.
DOI : 10.1126/science.1097670

G. Ahlenstiel, M. Martin, X. Gao, M. Carrington, and B. Rehermann, Distinct KIR/HLA compound genotypes affect the kinetics of human antiviral natural killer cell responses, Journal of Clinical Investigation, vol.118, pp.1017-1026, 2008.
DOI : 10.1172/JCI32400

U. Seifert, H. Liermann, V. Racanelli, A. Halenius, M. Wiese et al., Hepatitis C virus mutation affects proteasomal epitope processing, Journal of Clinical Investigation, vol.114, issue.2, pp.250-259, 2004.
DOI : 10.1172/JCI200420985
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC449747/pdf

B. Rehermann and M. Nascimbeni, Immunology of hepatitis B virus and hepatitis C virus infection, Nature Reviews Immunology, vol.24, issue.3, pp.215-229, 2005.
DOI : 10.1172/JCI200318509

R. Welsh and L. Selin, No one is naive: the significance of heterologous T-cell immunity, Nat Rev Immunol, vol.2, pp.417-426, 2002.

S. Urbani, B. Amadei, P. Fisicaro, M. Pilli, G. Missale et al., Heterologous T cell immunity in severe hepatitis C virus infection, The Journal of Experimental Medicine, vol.100, issue.5, pp.675-680, 2005.
DOI : 10.1002/hep.20332
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2212827

J. Helft, A. Jacquet, N. Joncker, I. Grandjean, G. Dorothee et al., Antigen-specific T-T interactions regulate CD4 T-cell expansion, Blood, vol.112, issue.4, pp.1249-1258, 2008.
DOI : 10.1182/blood-2007-09-114389
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2515122

B. Neveu, E. Debeaupuis, K. Echasserieau, L. Moullac-vaidye, B. Gassin et al., Selection of high-avidity CD8 T cells correlates with control of hepatitis C virus infection, Hepatology, vol.6, issue.3, pp.713-722, 2008.
DOI : 10.1002/hep.22379
URL : https://hal.archives-ouvertes.fr/pasteur-01402305

A. Sharpe and G. Freeman, THE B7???CD28 SUPERFAMILY, Nature Reviews Immunology, vol.12, issue.2, pp.116-126, 2002.
DOI : 10.1038/35069118

S. Urbani, B. Amadei, D. Tola, M. Massari, S. Schivazappa et al., PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion, Journal of Virology, vol.80, issue.22, pp.11398-11403, 2006.
DOI : 10.1128/JVI.01177-06

V. Kasprowicz, J. Schulze-zur-wiesch, T. Kuntzen, B. Nolan, S. Longworth et al., High Level of PD-1 Expression on Hepatitis C Virus (HCV)-Specific CD8+ and CD4+ T Cells during Acute HCV Infection, Irrespective of Clinical Outcome, Journal of Virology, vol.82, issue.6, pp.3154-3160, 2008.
DOI : 10.1128/JVI.02474-07

D. Butera, S. Marukian, A. Iwamaye, E. Hembrador, T. Chambers et al., Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C, Blood, vol.106, issue.4, pp.1175-1182, 2005.
DOI : 10.1182/blood-2005-01-0126

J. Banchereau and R. Steinman, Dendritic cells and the control of immunity, Nature, vol.392, issue.6673, pp.245-252, 1998.
DOI : 10.1038/32588

S. Auffermann-gretzinger, E. Keeffe, and S. Levy, Impaired dendritic cell maturation in patients with chronic, but not resolved, hepatitis C virus infection, Blood, vol.97, issue.10, pp.3171-3176, 2001.
DOI : 10.1182/blood.V97.10.3171

C. Bain, A. Fatmi, F. Zoulim, J. Zarski, C. Trepo et al., Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection, Gastroenterology, vol.120, issue.2, pp.512-524, 2001.
DOI : 10.1053/gast.2001.21212

T. Kanto, M. Inoue, H. Miyatake, A. Sato, M. Sakakibara et al., Reduced Numbers and Impaired Ability of Myeloid and Plasmacytoid Dendritic Cells to Polarize T Helper Cells in Chronic Hepatitis C Virus Infection, The Journal of Infectious Diseases, vol.190, issue.11, pp.1919-1926, 2004.
DOI : 10.1086/425425

R. Longman, A. Talal, I. Jacobson, M. Albert, and C. Rice, Presence of functional dendritic cells in patients chronically infected with hepatitis C virus, Blood, vol.103, issue.3, pp.1026-1029, 2004.
DOI : 10.1182/blood-2003-04-1339
URL : https://hal.archives-ouvertes.fr/pasteur-01402381

C. Bigger, K. Brasky, and R. Lanford, DNA Microarray Analysis of Chimpanzee Liver during Acute Resolving Hepatitis C Virus Infection, Journal of Virology, vol.75, issue.15, pp.7059-7066, 2001.
DOI : 10.1128/JVI.75.15.7059-7066.2001

A. Su, J. Pezacki, L. Wodicka, A. Brideau, L. Supekova et al., Nonlinear partial differential equations and applications: Genomic analysis of the host response to hepatitis C virus infection, Proceedings of the National Academy of Sciences, vol.99, issue.24, pp.15669-15674, 2002.
DOI : 10.1073/pnas.202608199

B. Lindenbach, M. Evans, A. Syder, B. Wolk, T. Tellinghuisen et al., Complete Replication of Hepatitis C Virus in Cell Culture, Science, vol.309, issue.5734, pp.623-626, 2005.
DOI : 10.1126/science.1114016

E. Meylan, J. Curran, K. Hofmann, D. Moradpour, M. Binder et al., Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus, Nature, vol.69, issue.7062, pp.1167-1172, 2005.
DOI : 10.1016/j.cell.2005.08.012

Y. Loo, D. Owen, K. Li, A. Erickson, C. Johnson et al., Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infection, Proceedings of the National Academy of Sciences, vol.103, issue.15, pp.6001-6006, 2006.
DOI : 10.1073/pnas.0601523103

R. Thimme, J. Bukh, H. Spangenberg, S. Wieland, J. Pemberton et al., Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease, Proceedings of the National Academy of Sciences, vol.99, issue.24, pp.15661-15668, 2002.
DOI : 10.1073/pnas.202608299

S. Mihm, M. Frese, V. Meier, P. Wietzke-braun, J. Scharf et al., Interferon type I gene expression in chronic hepatitis C, Laboratory Investigation, vol.63, issue.9, pp.1148-1159, 2004.
DOI : 10.1038/labinvest.3700135

H. Peter, H. Dallugge, R. Zawatzky, S. Euler, W. Leibold et al., Human peripheral null lymphocytes II. Producers of type-1 interferon upon stimulation with tumor cells, Herpes simplex virus andCorynebacterium parvum, European Journal of Immunology, vol.7, issue.7, pp.547-555, 1980.
DOI : 10.1002/eji.1830100712

G. Trinchieri, D. Santoli, R. Dee, and B. Knowles, Anti-viral activity induced by culturing lymphocytes with tumor-derived or virus-transformed cells. Identification of the anti-viral activity as interferon and characterization of the human effector lymphocyte subpopulation, Journal of Experimental Medicine, vol.147, issue.5, pp.1299-1313, 1978.
DOI : 10.1084/jem.147.5.1299
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2184278

N. Kadowaki, S. Antonenko, J. Lau, and Y. Liu, Natural Interferon ??/?????Producing Cells Link Innate and Adaptive Immunity, The Journal of Experimental Medicine, vol.157, issue.2, pp.219-226, 2000.
DOI : 10.1146/annurev.iy.12.040194.005015
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2193254/pdf

T. Ito, H. Kanzler, O. Duramad, W. Cao, and Y. Liu, Specialization, kinetics, and repertoire of type 1 interferon responses by human plasmacytoid predendritic cells, Blood, vol.107, issue.6, pp.2423-2431, 2006.
DOI : 10.1182/blood-2005-07-2709

M. Cella, D. Jarrossay, F. Facchetti, O. Alebardi, H. Nakajima et al., Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon, Nat Med, vol.5, pp.919-923, 1999.

W. Lai, S. Curbishley, S. Goddard, E. Alabraba, J. Shaw et al., Hepatitis C is associated with perturbation of intrahepatic myeloid and plasmacytoid dendritic cell function, Journal of Hepatology, vol.47, issue.3, pp.338-347, 2007.
DOI : 10.1016/j.jhep.2007.03.024

H. Yoneyama, K. Matsuno, Y. Zhang, T. Nishiwaki, M. Kitabatake et al., Evidence for recruitment of plasmacytoid dendritic cell precursors to inflamed lymph nodes through high endothelial venules, International Immunology, vol.16, issue.7, pp.915-928, 2004.
DOI : 10.1093/intimm/dxh093

T. Matsutani, T. Tanaka, K. Tohya, K. Otani, M. Jang et al., Plasmacytoid dendritic cells employ multiple cell adhesion molecules sequentially to interact with high endothelial venule cells - molecular basis of their trafficking to lymph nodes, International Immunology, vol.19, issue.9, pp.1031-1037, 2007.
DOI : 10.1093/intimm/dxm088

G. Penna, S. Sozzani, and L. Adorini, Cutting Edge: Selective Usage of Chemokine Receptors by Plasmacytoid Dendritic Cells, The Journal of Immunology, vol.167, issue.4, pp.1862-1866, 2001.
DOI : 10.4049/jimmunol.167.4.1862

D. Stetson and R. Medzhitov, Type I Interferons in Host Defense, Immunity, vol.25, issue.3, pp.373-381, 2006.
DOI : 10.1016/j.immuni.2006.08.007
URL : http://doi.org/10.1016/j.immuni.2006.08.007

C. Lee, D. Rao, R. Gertner, R. Gimeno, A. Frey et al., Distinct Requirements for IFNs and STAT1 in NK Cell Function, The Journal of Immunology, vol.165, issue.7, pp.3571-3577, 2000.
DOI : 10.4049/jimmunol.165.7.3571

K. Nguyen, T. Salazar-mather, M. Dalod, J. Van-deusen, X. Wei et al., Coordinated and Distinct Roles for IFN-????, IL-12, and IL-15 Regulation of NK Cell Responses to Viral Infection, The Journal of Immunology, vol.169, issue.8, pp.4279-4287, 2002.
DOI : 10.4049/jimmunol.169.8.4279

G. Kolumam, S. Thomas, L. Thompson, J. Sprent, and K. Murali-krishna, Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection, The Journal of Experimental Medicine, vol.4, issue.5, pp.637-650, 2005.
DOI : 10.1038/37648

S. Gallucci, M. Lolkema, and P. Matzinger, Natural adjuvants: Endogenous activators of dendritic cells, Nature Medicine, vol.81, issue.11, pp.1249-1255, 1999.
DOI : 10.1146/annurev.immunol.2.1.461

T. Luft, K. Pang, E. Thomas, P. Hertzog, D. Hart et al., Type I IFNs enhance the terminal differentiation of dendritic cells, J Immunol, vol.161, pp.1947-1953, 1998.

M. Montoya, G. Schiavoni, F. Mattei, I. Gresser, F. Belardelli et al., Type I interferons produced by dendritic cells promote their phenotypic and functional activation, Blood, vol.99, issue.9, pp.3263-3271, 2002.
DOI : 10.1182/blood.V99.9.3263

H. Yoneyama, K. Matsuno, E. Toda, T. Nishiwaki, N. Matsuo et al., Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs, The Journal of Experimental Medicine, vol.160, issue.3, pp.425-435, 2005.
DOI : 10.1084/jem.180.5.1889
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213078

J. Decalf, S. Fernandes, R. Longman, M. Ahloulay, F. Audat et al., Plasmacytoid dendritic cells initiate a complex chemokine and cytokine network and are a viable drug target in chronic HCV patients, The Journal of Experimental Medicine, vol.42, issue.10, pp.2423-2437, 2007.
DOI : 10.1038/nri1329
URL : https://hal.archives-ouvertes.fr/pasteur-01402312

D. Piccioli, S. Tavarini, S. Nuti, P. Colombatto, M. Brunetto et al., Comparable functions of plasmacytoid and monocyte-derived dendritic cells in chronic hepatitis C patients and healthy donors, Journal of Hepatology, vol.42, issue.1, pp.61-67, 2005.
DOI : 10.1016/j.jhep.2004.09.014

H. Murakami, S. Akbar, H. Matsui, N. Horiike, and M. Onji, Decreased interferon-alpha production and impaired T helper 1 polarization by dendritic cells from patients with chronic hepatitis C, Clinical and Experimental Immunology, vol.146, issue.3, pp.559-565, 2004.
DOI : 10.1016/S0092-8674(01)00448-2

G. Szabo and A. Dolganiuc, Subversion of plasmacytoid and myeloid dendritic cell functions in chronic HCV infection, Immunobiology, vol.210, issue.2-4, pp.237-247, 2005.
DOI : 10.1016/j.imbio.2005.05.018

R. Longman, A. Talal, I. Jacobson, C. Rice, and M. Albert, Normal Functional Capacity in Circulating Myeloid and Plasmacytoid Dendritic Cells in Patients with Chronic Hepatitis C, The Journal of Infectious Diseases, vol.192, issue.3, pp.497-503, 2005.
DOI : 10.1086/431523
URL : https://hal.archives-ouvertes.fr/pasteur-01402357

A. Dzionek, Y. Sohma, J. Nagafune, M. Cella, M. Colonna et al., BDCA-2, a Novel Plasmacytoid Dendritic Cell???specific Type II C-type Lectin, Mediates Antigen Capture and Is a Potent Inhibitor of Interferon ??/?? Induction, The Journal of Experimental Medicine, vol.147, issue.12, pp.1823-1834, 2001.
DOI : 10.1016/S0167-5699(00)01745-X

M. Evans, T. Von-hahn, D. Tscherne, A. Syder, M. Panis et al., Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry, Nature, vol.23, issue.7137, pp.801-805, 2007.
DOI : 10.1038/nature05654

A. Kraft, F. Krux, S. Schimmer, C. Ohlen, P. Greenberg et al., CpG Oligodeoxynucleotides allow for effective adoptive T-cell therapy in chronic retroviral infection, Blood, vol.109, pp.2982-2984, 2007.
DOI : 10.1182/blood-2006-06-022178

A. Lonsdorf, H. Kuekrek, B. Stern, B. Boehm, P. Lehmann et al., Intratumor CpG-Oligodeoxynucleotide Injection Induces Protective Antitumor T Cell Immunity, The Journal of Immunology, vol.171, issue.8, pp.3941-3946, 2003.
DOI : 10.4049/jimmunol.171.8.3941

R. Vabulas, H. Pircher, G. Lipford, H. Hacker, and H. Wagner, CpG-DNA Activates In Vivo T Cell Epitope Presenting Dendritic Cells to Trigger Protective Antiviral Cytotoxic T Cell Responses, The Journal of Immunology, vol.164, issue.5, pp.2372-2378, 2000.
DOI : 10.4049/jimmunol.164.5.2372

A. Gelman, D. Larosa, J. Zhang, P. Walsh, Y. Choi et al., The Adaptor Molecule MyD88 Activates PI-3 Kinase Signaling in CD4+ T Cells and Enables CpG Oligodeoxynucleotide-Mediated Costimulation, Immunity, vol.25, issue.5, pp.783-793, 2006.
DOI : 10.1016/j.immuni.2006.08.023

B. Piqueras, J. Connolly, H. Freitas, A. Palucka, and J. Banchereau, Upon viral exposure, myeloid and plasmacytoid dendritic cells produce 3 waves of distinct chemokines to recruit immune effectors, Blood, vol.107, issue.7, pp.2613-2618, 2006.
DOI : 10.1182/blood-2005-07-2965

J. Mchutchison, B. Bacon, S. Gordon, E. Lawitz, M. Shiffman et al., Phase 1B, randomized, double-blind, dose-escalation trial of CPG 10101 in patients with chronic hepatitis C virus, Hepatology, vol.44, issue.Suppl 1, pp.1341-1349, 2007.
DOI : 10.1002/hep.21773

J. Mchutchison, Immunophenotyping profile of CpG 10101 (ACTILON), a new TLR9 agonist antiviral ofr hepatitis C, Hepatology, vol.42, p.539, 2005.

E. Yamada, M. Montoya, C. Schuettler, T. Hickling, A. Tarr et al., Analysis of the binding of hepatitis C virus genotype 1a and 1b E2 glycoproteins to peripheral blood mononuclear cell subsets, Journal of General Virology, vol.86, issue.9, pp.2507-2512, 2005.
DOI : 10.1099/vir.0.81169-0
URL : https://hal.archives-ouvertes.fr/hal-00105470

P. Pileri, Y. Uematsu, S. Campagnoli, G. Galli, F. Falugi et al., Binding of Hepatitis C Virus to CD81, Science, vol.282, issue.5390, pp.938-941, 1998.
DOI : 10.1126/science.282.5390.938

E. Scarselli, H. Ansuini, R. Cerino, R. Roccasecca, S. Acali et al., The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus, The EMBO Journal, vol.269, issue.19, pp.5017-5025, 2002.
DOI : 10.1093/emboj/cdf529

Z. Yao, S. Ray, A. Eisen-vandervelde, S. Waggoner, and Y. Hahn, Hepatitis C Virus: Immunosuppression by Complement Regulatory Pathway, Viral Immunology, vol.14, issue.4, pp.277-295, 2001.
DOI : 10.1089/08828240152716547

M. Shiina and B. Rehermann, Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function, Hepatology, vol.214, issue.2, pp.385-395, 2007.
DOI : 10.1002/hep.21996